Fox Run Management L.L.C. raised its stake in Tenet Healthcare Co. (NYSE:THC – Free Report) by 114.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,319 shares of the company’s stock after acquiring an additional 2,838 shares during the period. Fox Run Management L.L.C.’s holdings in Tenet Healthcare were worth $671,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. True Wealth Design LLC bought a new position in Tenet Healthcare during the 3rd quarter valued at about $38,000. WR Wealth Planners LLC boosted its holdings in shares of Tenet Healthcare by 2,836.4% in the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock worth $41,000 after acquiring an additional 312 shares in the last quarter. Smartleaf Asset Management LLC grew its position in Tenet Healthcare by 30.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after acquiring an additional 110 shares during the last quarter. Kestra Investment Management LLC bought a new position in Tenet Healthcare in the 4th quarter valued at $60,000. Finally, Wilmington Savings Fund Society FSB grew its holdings in shares of Tenet Healthcare by 1,352.8% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock worth $66,000 after purchasing an additional 487 shares during the last quarter. 95.44% of the stock is owned by institutional investors.
Tenet Healthcare Stock Up 5.4 %
THC opened at $129.87 on Tuesday. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The stock’s fifty day simple moving average is $132.22 and its 200 day simple moving average is $142.92. Tenet Healthcare Co. has a 1-year low of $90.03 and a 1-year high of $171.20. The stock has a market cap of $12.35 billion, a PE ratio of 4.03, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06.
Analyst Ratings Changes
Several equities research analysts have weighed in on the stock. Wells Fargo & Company cut shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $205.00 to $150.00 in a research report on Monday, November 25th. StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. KeyCorp lowered their target price on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Finally, TD Cowen began coverage on shares of Tenet Healthcare in a research report on Wednesday, February 26th. They set a “buy” rating and a $175.00 target price on the stock. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $163.88.
View Our Latest Analysis on Tenet Healthcare
Insider Buying and Selling
In other news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares of the company’s stock, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.93% of the stock is currently owned by insiders.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
- Five stocks we like better than Tenet Healthcare
- Insider Trades May Not Tell You What You Think
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Dividend Payout Ratio Calculator
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Insider Trading – What You Need to Know
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.